Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEARCH
NCT00124072Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 1998
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of simvastatin, folic acid and vitamin b12 in myocardial infarction (MI) (4 arms), sponsored by University of Oxford. Primary endpoint: Major Vascular Events at 6.7 years. Started Jul 1998; status: completed.
02
Drugs
simvastatinfolic acidvitamin b12
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00124072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124072.